If you have first-hand knowledge of the FDA’s torpor, get in touch
Albuterol Inhalers.<p>Used to use CFC as the propellant.  CFCs got banned.  So,  the FDA lets GSK _re-patent_ the same *medication* but just with a new propellant.<p>What propellant did they use?  R-134a.  The same HFA that everyone switched to after CFC was taken out of use for refigeration.<p>It wasn't even a novel change.<p>Inhalers went from $5 generics to $90 brand name only overnight.  Of course,  GSK also secured further patents that prevented things from primatine mist from existing at all.  Disappeared from the market and primatine tablets were the only thing left.<p>Oh..  and R-134a is getting phased out again soon.  Just in time for the GSK patents to be renewed,  I guess.  So,  they're going to leave people who need a simple medication for breathing issues without anything on the market,  _again_.  I wonder if they'll even get the single year of "generic tease" again.